Found 500 news articles for
-
Australian scientists find genetic cause of lupus
An international study that found a novel genetic cause of lupus owes much of its success to a single lab in Melbourne. Associate Professor Michael Gantier The discovery of a…… Read more
-
Professor Elizabeth Hartland to Chair VicAAMRI
The CEO of Hudson Institute of Medical Research, Professor Elizabeth Hartland, has been appointed Chair of the Victorian Chapter of the Association of Australian Medical Research Institutes, VicAMMRI. Professor Elizabeth…… Read more
-
Reducing preterm stillbirth
With a record of successfully changing the way many Australians give birth, a team from Hudson Institute now wants to change how we think about perinatal death, especially reducing preterm…… Read more
-
Victorian Premier’s Awards recognise rising stars
Hudson Institute has featured prominently in the Victorian Premier’s Awards for Health and Medical Research, thanks to pioneering work developing new treatments for pelvic organ prolapse (POP). L–R: Dr Kallyanashis…… Read more
-
Helping pre-term babies avoid bronchopulmonary dysplasia by controlling inflammatory response
Medical researchers are a big step closer to understanding and controlling the inflammatory responses in pre-terms that can cause devastating heart and lung conditions including bronchopulmonary dysplasia (BPD) and pulmonary…… Read more
-
Obesity during pregnancy affects baby and placenta – but impacts vary depending on sex
Maternal obesity during pregnancy can negatively affect both the growth and health of the baby and the function of the placenta, but new research also finds the impacts vary depending…… Read more
-
GPs take a second look at primary aldosteronism and high blood pressure
A simple blood test for primary aldosteronism could save more than half a million Australians from unnecessary illness, medication and expense, a new study has found. PhD Student, Renata Libianto…… Read more
-
Uncovering the mechanism driving antimicrobial resistance
The World Health Organization calls antimicrobial resistance (AMR) “one of the most urgent health threats of our time” and now, thanks to a collaboration between the Hudson Institute of Medical…… Read more
-
Targeting viral lung infections two ways
A new anti-viral drug to target the cause of viral lung infections and the infection itself, could be a game-changer in treating severe influenza. Associate Professor Michelle Tate There are…… Read more
-
Germline Stem Cell Biology team wins ARC Discovery grant
An RNA project with potential in both male infertility and cancer has been awarded significant funding by the Australian Research Council. L–R: A/Prof Robin Hobbs, Dr Minni (Minna-Liisa) Änkö Associate…… Read more